Cargando…
Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil
SIMPLE SUMMARY: Cancer patients present a distinct vulnerability to COVID-19. It is unclear if chemotherapy per se increases the overall risk in this population. In our study, we analyzed retrospective COVID-19 data linked to oncological information systems to evaluate outcomes in COVID-19 cancer pa...
Autores principales: | Duarte, Mateus Bringel Oliveira, Leal, Frederico, Argenton, Juliana Luz Passos, Carvalheira, José Barreto Campello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760330/ https://www.ncbi.nlm.nih.gov/pubmed/33255220 http://dx.doi.org/10.3390/cancers12123490 |
Ejemplares similares
-
Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
por: Duarte, Mateus Bringel Oliveira, et al.
Publicado: (2021) -
Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis
por: Duarte, Mateus B.O., et al.
Publicado: (2022) -
Chemoradiotherapy With or Without Surgery for Esophageal Squamous Cancer According to Hospital Volume
por: Duarte, Mateus Bringel Oliveira, et al.
Publicado: (2020) -
Metformin and blood cancers
por: Cunha Júnior, Ademar Dantas, et al.
Publicado: (2018) -
Repurposing metformin for the treatment of gastrointestinal cancer
por: Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021)